Metropolitan Life Insurance Company (MetLife)’s Carisma Therapeutics CARM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,470	Closed	-$6.22K	–	2353
2023 Q3	$6.22K	Hold	1,470	–	–	﹤0.01%	2377
2023 Q2	$12.9K	Buy	+1,470	New	+$12.9K	﹤0.01%	2164
2021 Q3	–	Sell	-2,506	Closed	-$232K	–	2843
2021 Q2	$232K	Buy	+2,506	New	+$232K	﹤0.01%	2039